Table 1.
Characteristic | Burkina Faso | Ethiopia | Malawi |
---|---|---|---|
Evaluation design | Quasi-experimental design: purposively selected intervention and randomly selected comparison districts | Randomized control trial: “woredas” (districts) randomized in intervention and comparison | Dose–response analysis for 28 districts |
Research partner(s) | Institut Supérieur des Sciences de la Population | MELA Research PLC; Alliance for Better Health Services PLC | National Statistical Office; Chancellor College, University of Malawi |
Intervention area for the evaluation | Nine districts (seven malaria and diarrhea only, two iCCM for the three illnesses) | 16 woredas | National, all 28 districts |
Comparison area | Seven districts | 15 woredas | No comparison area |
Baseline–Endline | 2010–2013 | 2011–2013 | 2010–2014 |
iCCM implementation strength assessment | 2013 | 2012 | 2013 |
iCCM quality of care assessment | 2012 | 2012 | 2009 |
Mortality measurement | Under-five mortality estimated using the Lives Saved Tool (LiST) | Under-five and 2–59 months mortality rates measured through full birth history, endline survey | Under-five and 2–59 months mortality rates measured through full birth history, endline survey |
Additional sub-studies | Qualitative study of iCCM utilization8 | Qualitative study of iCCM utilization9 | Qualitative study of health system supports for iCCM10 |
iCCM = integrated community case management.